Patel Sanjiv's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Jan 23, 2025
- Accession no.
- 0000950170-25-008451
- Filed
- Jan 23, 2025
- Trade date
- Jan 21-23, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.76M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel SanjivCIK 0001816210 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | Common Stock | SSaleDisposed | −125,000 | $4.52 | −$565,000 | 449,548 | Indirect | |
| Jan 22, 2025 | Common Stock | SSaleDisposed | −125,000 | $4.80 | −$600,000 | 324,548 | Indirect | |
| Jan 23, 2025 | Common Stock | SSaleDisposed | −125,000 | $4.78 | −$597,500 | 199,548 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.